Idelberto Badell, MD
Surgery · Atlanta, GANPI 1972787257
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,889 of the $26,585 with a category attached, or 89.9%. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 47.8% of the total. Among surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $1772.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$13K
- Veloxis Pharmaceuticals, Inc.$8K
- E.r. Squibb & Sons, L.L.C.$4K
- Intuitive Surgical$902
- Medtronic$173
Across 10 payments — averaging $388,517 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$3.9M
What the payments were for
- Consulting fees$23,88990%
- Travel & lodging$1,3045%
- Food & beverage$6432%
- Education$7503%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 7 | $12,713 |
| Veloxis Pharmaceuticals, Inc. | 3 | $8,437 |
| E.r. Squibb & Sons, L.L.C. | 1 | $4,360 |
| Intuitive Surgical | 3 | $902 |
| Medtronic | 1 | $173 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$8,409
- DAVINCI XI$750
- Signia$173
- Da Vinci Surgical System$135
How this compares
$26,585 in reported general payments places this provider in the 90th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 153 | $24,579 |
| Envarsus XrTacrolimus | 21 | $21,912 |
| Atovaquone | 32 | $12,995 |
| Nifedipine ErNifedipine | 147 | $4,557 |
| Mycophenolate Mofetil | 37 | $2,360 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 39 | $2,216 |
| Humalog Kwikpen U-100Insulin Lispro | 18 | $2,053 |
| Novolog FlexpenInsulin Aspart | 17 | $1,412 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 256 | $944 |
| ValacyclovirValacyclovir Hcl | 21 | $607 |
| Prednisone | 190 | $578 |
| Atorvastatin Calcium | 190 | $533 |
| Pantoprazole Sodium | 33 | $175 |
| Carvedilol | 58 | $154 |
| Hydralazine Hcl | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Other surgery in Atlanta
- Kendra GrubbAtlanta$374K
- Ankit PatelAtlanta$217K
- Kevin NguyenAtlanta$161K
- Nathaniel LytleAtlanta$118K
- David ParkAtlanta$112K
- Dominic PapandriaAtlanta$60K
- Kenneth NewellAtlanta$50K
- Marwan KazimiAtlanta$33K
- Charles ProcterAtlanta$27K
- Vishwanath DanthuluriAtlanta$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.